IP Library Granted Patent US 10,825,553
Granted Patent B2
US 10,825,553 · App. 15/900,723 · Granted Nov 3, 2020

Methods for genome assembly and haplotype phasing

Inventors: Richard E. Green, Jr. (Santa Cruz, CA); Liana F. Lareau (San Francisco, CA)
Assignee: The Regents of the University of California
G16B30/00C12Q1/6874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,825,553
App. No.
15/900,723
Granted
Nov 3, 2020
Kind
B2
Abstract

The disclosure provides methods to assemble genomes of eukaryotic or prokaryotic organisms. The disclosure further provides methods for haplotype phasing and meta-genomics assemblies.

Claims (30)

1. A method of genome assembly, comprising:

contacting a sample to a stabilizing agent, said sample comprising a nucleic acid molecule complexed to at least one nucleic acid binding protein;

cleaving the nucleic acid into a plurality of segments comprising at least a first segment and a second segment;

attaching the first segment and the second segment at a junction;

obtaining at least some sequence on each side of the junction to generate a first read pair;

mapping the first read pair to a set of contigs; and

determining a path through the set of contigs that represents an order and/or orientation to a genome.

2. The method of claim 1 , comprising:

excluding the first read pair from contig assembly analysis because said at least some sequence on each side of the junction maps to a common contig; and

determining a path through the contigs that represents an order and/or orientation to the genome using a second read pair.

3. The method of claim 1 , comprising:

contacting the sample to an antibody prior to contacting the sample to the stabilizing agent.

4. The method of claim 1 , comprising:

contacting the sample to an antibody subsequent to contacting the sample to the stabilizing agent.

5. The method of claim 1 , wherein cleaving the nucleic acid into at least a first segment and a second segment comprises cutting the nucleic acid using at least one restriction enzyme.

6. The method of claim 1 , wherein cleaving the nucleic acid into at least a first segment and a second segment comprises shearing the nucleic acid.

7. The method of claim 1 , wherein cleaving the nucleic acid into at least a first segment and a second segment comprises sonicating the nucleic acid.

8. The method of claim 1 , wherein contacting a sample to a stabilizing agent comprises administering ultraviolet light.

9. The method of claim 1 , wherein contacting a sample to a stabilizing agent comprises contacting the sample to a chemical fixative.

10. The method of claim 9 , wherein the chemical fixative comprises formaldehyde.

11. The method of claim 9 , wherein the chemical fixative comprises psoralen.

12. The method of claim 1 , wherein the at least one nucleic acid binding protein comprises a native chromatin constituent.

13. The method of claim 1 , wherein the at least one nucleic acid binding protein comprises an exogenously supplied histone.

14. The method of claim 1 , wherein attaching comprises filling in sticky ends using at least some biotin tagged nucleotides and ligating the blunt ends.

15. The method of claim 1 , wherein the path through the set of contigs that represents an order and/or orientation to the genome is determined so that each contig is visited exactly once.

16. The method of claim 1 , wherein determining a path through the set of contigs that represents an order and/or orientation to the genome comprises down-weighing contigs that represent promiscuous regions of the genome.

17. The method of claim 1 , wherein the set of contigs is generated by a shotgun sequencing method.

18. The method of claim 1 , wherein determining a path through the set of contigs that represents an order and/or orientation to the genome comprises haplotype phasing the set of contigs.

19. The method of claim 18 , wherein haplotype phasing the set of contigs comprise identifying one or more sites of heterozygosity in a plurality of read pair sequences, wherein phasing data for allelic variants is determined by identifying read pairs that comprise a pair of heterozygous sites.

20. The method of claim 1 , comprising excluding from analysis read pair sequence that maps to a common contig, so as to determine a path through the set of contigs that represents an order and/or orientation to the genome using read pairs that map to different contigs.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2020
From: GREEN, RICHARD E., JR.; LAREAU, LIANA F.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 052999/0308 →
Continuity (4)
Continuation 15167880 · May 27, 2016
Continuation 14170339 · Jan 31, 2014
Provisional Application 61759941 · Feb 1, 2013
Related Publication 20180365376A1 · Dec 20, 2018
Cited By (4)
US 12,378,592 US 12,404,537 US 12,444,480 US 12,725,678